Abstract:Increased vascular endothelial cell (EC) permeability is a result of intercellular gap formation that may be induced by contraction-dependent and contraction-independent mechanisms. This study investigated a role of the adaptor protein vinculin in EC permeability induced by contractile (thrombin) and noncontractile (IL-6) agonists. Although thrombin and IL-6 caused a similar permeability increase in human pulmonary ECs and disrupted the association between vinculin and vascular endothelial-cadherin, they induced different patterns of focal adhesion (FA) arrangement. Thrombin, but not IL-6, caused formation of large, vinculin-positive FAs, phosphorylation of FA proteins, FA kinase and Crk-associated substrate, and increased vinculin-talin association. Thrombin-induced formation of talin-positive FA and intercellular gaps were suppressed in ECs with small interfering RNA-induced vinculin knockdown. Vinculin knockdown and inhibitors of Rho kinase and myosin-II motor activity also attenuated thrombin-induced EC permeability. Importantly, ectopic expression of the vinculin mutant lacking the F-actin-binding domain decreased thrombin-induced Rho pathway activation and EC permeability. In contrast, IL-6-induced EC permeability did not involve RhoA- or myosin-dependent mechanisms but engaged Janus kinase/signal transducer and activator of transcription-mediated phosphorylation and internalization of vascular endothelial-cadherin. This process was vinculin independent but Janus kinase/tyrosine kinase Src-dependent. These data suggest that vinculin participates in a contractile-dependent mechanism of permeability by integrating FA with stress fibers, leading to maximal RhoA activation and EC permeability response. Vinculin inhibition does not affect contractile-independent mechanisms of EC barrier failure. This study provides, for the first time, a comparative analysis of two alternative mechanisms of vascular endothelial barrier dysfunction and defines a specific role for vinculin in the contractile type of permeability response.

VE-cadherin and claudin-5: it takes two to tango

Breaking the VE-cadherin bonds

Molecular mechanism of VE-cadherin in regulating endothelial cell behaviour during angiogenesis

Ve-Cadherin is A Critical Endothelial Regulator of Tgf-Beta Signalling

In tight junctions, claudins regulate the interactions between occludin, tricellulin and marvelD3, which, inversely, modulate claudin oligomerization

Biophysics of claudin proteins in tight junction architecture: Three decades of progress

Junctions at the Crossroads: The Impact of Mechanical Cues on Endothelial Cell-Cell Junction Conformations and Vascular Permeability

Claudin-5 participates in the regulation of endothelial cell motility

Overlapping and divergent signaling pathways of N-cadherin and VE-cadherin in endothelial cells

Heterogeneity of endothelial VE-PTP downstream polarization, Tie2 activation, junctional claudin-5, and permeability in the aorta and vena cava

The VE-Cadherin/β-catenin signalling axis regulates immune cell infiltration into tumours

An EMMPRIN-γ-catenin-Nm23 complex drives ATP production and actomyosin contractility at endothelial junctions

Calcium-modulated cis and trans E-cadherin EC1-2 interactions play a key role in formation, dynamics and plasticity of cadherin junctions

Biophysical Basis of Paracellular Barrier Modulation by a Pan-Claudin-Binding Molecule

Cortactin is in a complex with VE-cadherin and is required for endothelial adherens junction stability through Rap1/Rac1 activation

A refined model of claudin-15 tight junction paracellular architecture by molecular dynamics simulations

Selective Role of Vinculin in Contractile Mechanisms of Endothelial Permeability.

The VE-cadherin/AmotL2 mechanosensory pathway suppresses aortic inflammation and the formation of abdominal aortic aneurysms

A Local VE-cadherin and Trio-based Signaling Complex Stabilizes Endothelial Junctions Through Rac1

Cadherin-Based Intercellular Adhesions Organize Epithelial Cell-Matrix Traction Forces

CLDN5: From structure and regulation to roles in tumors and other diseases beyond CNS disorders